133 related articles for article (PubMed ID: 38187726)
1. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates.
Malewana RD; Stalls V; May A; Lu X; Martinez DR; Schäfer A; Li D; Barr M; Sutherland LL; Lee E; Parks R; Beck WE; Newman A; Bock KW; Minai M; Nagata BM; DeMarco CT; Denny TN; Oguin TH; Rountree W; Wang Y; Mansouri K; Edwards RJ; Sempowski GD; Eaton A; Muramatsu H; Henderson R; Tam Y; Barbosa C; Tang J; Cain DW; Santra S; Moore IN; Andersen H; Lewis MG; Golding H; Seder R; Khurana S; Montefiori DC; Pardi N; Weissman D; Baric RS; Acharya P; Haynes BF; Saunders KO
bioRxiv; 2023 Dec; ():. PubMed ID: 38187726
[TBL] [Abstract][Full Text] [Related]
2. Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.
da Silva ES; Kohnen M; Gilson G; Staub T; Arendt V; Hilger C; Servais JY; Charpentier E; Domingues O; Snoeck CJ; Ollert M; Seguin-Devaux C; Perez-Bercoff D
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887023
[TBL] [Abstract][Full Text] [Related]
3. A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2.
He C; Alu A; Lei H; Yang J; Hong W; Song X; Li J; Yang L; Wang W; Shen G; Lu G; Wei X
MedComm (2020); 2023 Jun; 4(3):e263. PubMed ID: 37125241
[TBL] [Abstract][Full Text] [Related]
4. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
5. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Walls AC; Miranda MC; Pham MN; Schäfer A; Greaney A; Arunachalam PS; Navarro MJ; Tortorici MA; Rogers K; O'Connor MA; Shireff L; Ferrell DE; Brunette N; Kepl E; Bowen J; Zepeda SK; Starr T; Hsieh CL; Fiala B; Wrenn S; Pettie D; Sydeman C; Johnson M; Blackstone A; Ravichandran R; Ogohara C; Carter L; Tilles SW; Rappuoli R; O'Hagan DT; Van Der Most R; Van Voorhis WC; McLellan JS; Kleanthous H; Sheahan TP; Fuller DH; Villinger F; Bloom J; Pulendran B; Baric R; King N; Veesler D
bioRxiv; 2021 Mar; ():. PubMed ID: 33758839
[TBL] [Abstract][Full Text] [Related]
6. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L
Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692
[TBL] [Abstract][Full Text] [Related]
7. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
[TBL] [Abstract][Full Text] [Related]
8. Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
Yang X; Duan H; Liu X; Zhang X; Pan S; Zhang F; Gao P; Liu B; Yang J; Chi X; Yang W
J Virol; 2023 Jul; 97(7):e0061023. PubMed ID: 37367229
[TBL] [Abstract][Full Text] [Related]
9. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
10. A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
Liu Z; Zhou J; Wang X; Xu W; Teng Z; Chen H; Chen M; Zhang G; Wang Y; Huang J; Wang Q; Jiang S; Lu L
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2221713120. PubMed ID: 36897979
[TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.
Feng Y; Yuan M; Powers JM; Hu M; Munt JE; Arunachalam PS; Leist SR; Bellusci L; Kim J; Sprouse KR; Adams LE; Sundaramurthy S; Zhu X; Shirreff LM; Mallory ML; Scobey TD; Moreno A; O'Hagan DT; Kleanthous H; Villinger FJ; Veesler D; King NP; Suthar MS; Khurana S; Baric RS; Wilson IA; Pulendran B
Sci Transl Med; 2023 May; 15(695):eadg7404. PubMed ID: 37163615
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
[TBL] [Abstract][Full Text] [Related]
13. A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants.
Haslwanter D; Dieterle ME; Wec AZ; O'Brien CM; Sakharkar M; Florez C; Tong K; Rappazzo CG; Lasso G; Vergnolle O; Wirchnianski AS; Bortz RH; Laudermilch E; Fels JM; Mengotto A; Malonis RJ; Georgiev GI; Quiroz JA; Wrapp D; Wang N; Dye KE; Barnhill J; Dye JM; McLellan JS; Daily JP; Lai JR; Herbert AS; Walker LM; Chandran K; Jangra RK
mBio; 2021 Oct; 12(5):e0247321. PubMed ID: 34607456
[TBL] [Abstract][Full Text] [Related]
14. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Walls AC; Miranda MC; Schäfer A; Pham MN; Greaney A; Arunachalam PS; Navarro MJ; Tortorici MA; Rogers K; O'Connor MA; Shirreff L; Ferrell DE; Bowen J; Brunette N; Kepl E; Zepeda SK; Starr T; Hsieh CL; Fiala B; Wrenn S; Pettie D; Sydeman C; Sprouse KR; Johnson M; Blackstone A; Ravichandran R; Ogohara C; Carter L; Tilles SW; Rappuoli R; Leist SR; Martinez DR; Clark M; Tisch R; O'Hagan DT; Van Der Most R; Van Voorhis WC; Corti D; McLellan JS; Kleanthous H; Sheahan TP; Smith KD; Fuller DH; Villinger F; Bloom J; Pulendran B; Baric RS; King NP; Veesler D
Cell; 2021 Oct; 184(21):5432-5447.e16. PubMed ID: 34619077
[TBL] [Abstract][Full Text] [Related]
15. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
16. A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
Yuan M; Chen X; Zhu Y; Dong X; Liu Y; Qian Z; Ye L; Liu P
J Virol; 2022 Aug; 96(16):e0077522. PubMed ID: 35916510
[TBL] [Abstract][Full Text] [Related]
17. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
Tai W; Zheng J; Zhang X; Shi J; Wang G; Guan X; Zhu J; Perlman S; Du L
Virus Res; 2023 Sep; 334():199156. PubMed ID: 37336390
[TBL] [Abstract][Full Text] [Related]
18. An
Atanasoff KE; Brambilla L; Adelsberg DC; Kowdle S; Stevens CS; Hung CT; Fu Y; Lim R; Tran L; Allen R; Andrew Duty J; Bajic G; Lee B; Tortorella D
bioRxiv; 2023 Apr; ():. PubMed ID: 37131698
[TBL] [Abstract][Full Text] [Related]
19. Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles.
Borghi M; Gallinaro A; Pirillo MF; Canitano A; Michelini Z; De Angelis ML; Cecchetti S; Tinari A; Falce C; Mariotti S; Capocefalo A; Chiantore MV; Iacobino A; Di Virgilio A; van Gils MJ; Sanders RW; Lo Presti A; Nisini R; Negri D; Cara A
Front Immunol; 2023; 14():1147953. PubMed ID: 37090707
[TBL] [Abstract][Full Text] [Related]
20. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.
Liu X; Park HS; Matsuoka Y; Santos C; Yang L; Luongo C; Moore IN; Johnson RF; Garza NL; Zhang P; Lusso P; Best SM; Buchholz UJ; Le Nouën C
bioRxiv; 2022 Dec; ():. PubMed ID: 36561185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
